Artificial intelligence (AI) is revolutionizing medical and biological research, particularly in disease diagnosis and treatment. Advanced models like ChatGPT, Gemini, DeepSeek, and Grok-2 are enhancing healthcare applications, enabling better disease screening and drug discovery. The integration of AI with single-cell genomics is providing deeper insights into disease mechanisms and immune responses.
AI technologies are not only improving diagnostic accuracy but also personalizing treatment strategies and optimizing nursing care. The exploration of AI in areas such as cancer immunotherapy and drug development highlights its potential to accelerate therapeutic innovations. This research topic invites contributions that further investigate the multifaceted applications of AI in healthcare.
• AI models enhance disease diagnosis and treatment planning in healthcare.
• Integration of AI with genomics reveals insights into immune responses.
AI is utilized to improve diagnostic accuracy and personalize treatment strategies in healthcare.
This technology, combined with AI, helps identify unique immune cell subsets and disease mechanisms.
Machine learning algorithms are applied to accelerate drug discovery and predict drug-target interactions.
ChatGPT is a state-of-the-art AI model that enhances natural language processing for healthcare applications.
DeepSeek is an AI model that aids in drug discovery and treatment planning through advanced data analysis.
Scientific Research Publishing 8month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.